We were able to partly reproduce the differences described in the only other metabolomics study investigating patients with PRKN-linked PD, where an elevation of fatty acids and oxidized lipids and a decrease of antioxidants, caffeine, and benzoate-related metabolites were reported. Here, PRKN is linked to Parkinson disease.